New 24-Valent pneumococcal vaccine shows promise in kids
NCT ID NCT06550830
First seen Jan 29, 2026 · Last updated May 16, 2026 · Updated 13 times
Summary
This study tested a new vaccine (PCV24) designed to protect children aged 2-17 against pneumococcal disease, which can cause pneumonia and meningitis. The trial involved 119 healthy children and checked for side effects and immune response. The vaccine aims to cover 24 strains of the bacteria, offering broader protection than current vaccines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangsu Provincial Center for Disease Control and Prevention (Jiangsu Provincial Academy of Preventive Medicine)
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.